Learn About Platelet Rich Plasma (PRP) Dosage in Tendons at #IOF2017

Nov 16, 2016 | News, Research

Are You Dosing PRP Wrong in Tendons? If you’re using 3-5X PRP in tendons you may be under dosing certain patients. Two articles have been published suggesting that higher concentrations of PRP cause tenocyte inhibition. Given that both studies had serious design...

Platelet Rich Plasma (PRP) and Why the IOF is Studying its Effects on Cultured Cells

Feb 16, 2016 | Research

By Dustin Berger, M.S. Platelets are small cell fragments within our blood that play important roles in the wound healing process. In addition to being responsible for stopping blood flow at a site of injury, platelets are loaded full of beneficial growth factors....

Companies Respond to IOF Findings Related to Placental Tissue-Derived Products

Jan 5, 2016 | Research

As a follow-up to our December 16, 2015 Press Release and as part of an initiative to help clarify these issues, this web page contains numerous links that may be useful in reviewing accurate information on placental derived products. Below is a table illustrating...

Interventional Orthopedics Foundation Shines Light on False Claims about Stem Cell Products

Dec 16, 2015 | Press, Research

BROOMFIELD, Colo.–(BUSINESS WIRE)–The Interventional Orthopedics Foundation (IOF), a 501c3 non-profit dedicated to providing education about regenerative orthopedic medicine, recently announced the results of independent lab tests showing an absence of...

In Vitro Evaluation of Injectable, Placental Tissue-Derived Products for Orthopedic Applications

Oct 25, 2015 | Research

As presented at the First Annual Interventional Orthopedics Foundation Conference on October 23rd, here is a link to view our latest research poster “In Vitro Evaluation of Injectable, Placental Tissue-Derived Products for Orthopedic Applications”. This...